ProShare Advisors’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22.8K Buy
+13,731
New +$23.2K ﹤0.01% 1822
2025
Q2
– Sell
-24,099
Closed -$21.1K – 2161
2025
Q1
$21.1K Sell
24,099
-6,780
-22% -$9.41K ﹤0.01% 2033
2024
Q4
$52.2K Buy
30,879
+11,250
+57% +$20.3K ﹤0.01% 2170
2024
Q3
$37.7K Buy
+19,629
New +$44.6K ﹤0.01% 2007

Other funds holding PROK

ProShare Advisors's PROK Position: Q3 2026 in Review

ProShare Advisors opened a new position in ProKidney (PROK) in Q3 2026: 13,731 shares worth $22.8K. The stake represents ﹤0.01% of the portfolio and ranks #1822 among its holdings. This is a return to the name: ProShare Advisors previously reported a position in PROK as recently as Q1 2025.

ProShare Advisors first reported a position in PROK in Q3 2024 and has held it in 4 quarters since. The position peaked at $52.2K in Q4 2024. 42 funds tracked by Wall St. Rank hold PROK as of Q3 2026.

  • ProShare Advisors held 13,731 shares of ProKidney worth $22.8K as of Q3 2026.
  • ProKidney was a new ProShare Advisors position in Q3 2026.
  • ProKidney made up ﹤0.01% of ProShare Advisors's portfolio in Q3 2026, its #1822 holding.
  • ProShare Advisors first reported a position in ProKidney in Q3 2024 and has held it in 4 quarters since.
  • ProShare Advisors's ProKidney position peaked at $52.2K in Q4 2024.
  • 42 funds tracked by Wall St. Rank held ProKidney as of Q3 2026.

Based on ProShare Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.